Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer

Clinical trial NCT04508803 · COMPLETED

Trial details

NCT number: NCT04508803
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment Efficacy

Start date: 2020-09-14
Primary completion: 2022-08-20
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.